Arcellx Stock (NASDAQ: ACLX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 455.706K |
Day Range | - - - |
52 Wk Range | 30.740 - 75.100 |
Market Cap | $2.904B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 8.12% |
Days to Cover | 8.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Arcellx (NASDAQ: ACLX) through any online brokerage.
Other companies in Arcellx’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Alkermes (NASDAQ:ALKS).
The latest price target for Arcellx (NASDAQ: ACLX) was reported by Needham on Thursday, April 11, 2024. The analyst firm set a price target for 81.00 expecting ACLX to rise to within 12 months (a possible 48.62% upside). 37 analyst firms have reported ratings in the last year.
The stock price for Arcellx (NASDAQ: ACLX) is $54.5 last updated April 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Arcellx.
Arcellx’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Arcellx.
Arcellx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.